PSMD1 and neoplasm: We have shown, for the first time, the potential of an anti-MSLN nanobody for PET/CT imaging and demonstrated the selective accumulation of [68Ga]Ga-NODAGA-S1 in MSLN+ tumour, with high contrast images, shortly after systemic injection.